Darwin Global Management, Ltd.
Q1 2021 13F-HR Holdings
Net value change ($000)
+152,285
(42.5%)
New positions
3
Sold out positions
3
Turnover %
23.3%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q4 2020
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| XLRN | 84,025 | 70.0% |
| BBIO | 81,610 | 173.1% |
| RLAY | 27,050 | NEW |
| FATE | 26,325 | 30.4% |
| MGNX | 9,115 | NEW |
| ARVN | 6,298 | 210.6% |
| KROS | 5,348 | NEW |
| GBIO | 653 | 11.7% |
Top Reduces (Value $000, Stocks/ETFs)
| Mirati Therapeutics, Inc. | -57,299 | -100.0% |
| SRPT | -19,589 | -100.0% |
| IMVT | -8,148 | -88.5% |
| CCCC | -2,393 | -31.6% |
| STOK | -372 | -100.0% |
| Inhibrx, Inc. | -207 | -17.2% |
| FULC | -131 | -18.2% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|